skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

This free white paper from Datamonitor Healthcare explores changes in the market access environment in Poland. An increasingly important European market, the Polish pharmaceutical market has recently undergone many changes. The Reimbursement Act, introduced in 2012, has had a negative impact on the reimbursed market segment in terms of changes in the reference pricing system and price renegotiation. However, the pricing and reimbursement process is now more transparent and predictable, and the introduction of risk-sharing schemes opens up opportunities for market access to high-cost therapies.

Highlights in this white paper include:

  • A discussion of the key measures of the Reimbursement Act of 2012 and their impact on the pharmaceutical market.
  • An analysis of the changes in the rate of addition of new medicines to reimbursement lists.
  • Insight into how risk-sharing schemes are used in Poland.

 

Changes in the Polish Market Whitepaper

Total pharmaceuticalsalesinPoland reached €5.0bn($6.6bn)in 2012,with key drivers of the market being the country's growing economy,increasing life expectancy, and an increase in per capita physician visits, offering substantial market potential for pharmaceutical products
Polish-pharmaceutical-market3

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: